scieee Science in your language
[hu] (orig)

A homocisztein szerepe a natív koronáriák és a véna graftok ateroszklerotikus megbetegedéseiben

Abstract

Magyar nyelvű összefoglaló: A koronária betegség (CAD) súlyos manifesztációi és azok szövődményei a fejlett társadalmak természetes és korai halálozásának jelentős okai. Az egyre nagyobb egészségügyi kiadások miatt elvárt, hogy a kardiológiai intervenció/prevenció többet jelentsen a „veszélyes” érszakaszok mechanikai revaszkularizációjánál. A széles körvben elérhető korszerű gyógyszeres és intervenciós technikák ellenére a natív koronáriák/graftok degeneratív elváltozásai, illetve szövődményei az életkilátás jelentős korlátozói. Ismert rizikófaktorainak, illetve társbetegségeinek jelentősége nem ritkán alábecsült, illetve kezelésük effektivitása elégtelen. Natív- és véna graftolt koronária betegek rizikófaktorai szerepének vizsgálatát tűztem ki kutatásom céljául. Kilencszázötvenöt CAD beteg adatait gyűjtöttük és elemeztük 1999-től 2007-ig, illetve 75 fős CABG-SVG (koronária áthidaló műtét saphena véna grafttal) alcsoport adatait 2013-ig: társbetegségeiket, rizikófaktoraikat, legalább 12 hónap után ismételt szelektív koronária angiográfiás vizsgálataik eredményeit rögzítettük és elemeztük. A natív koronária betegeket szignifikáns koronária szűkület/korábbi miokardiális infarktus (MI) jelenléte/hiánya alapján 4 csoportba soroltam, szignifikáns szűkület és MI negatív személyek képezték a kontroll csoportot. A 75 fős, CABG során véna graftot (SVG) kapott betegeket az SVG utánkövetéskori státusza szerint “intact” (<20%); “szűkült” (20-99%) és elzáródott csoportba soroltam. Eredményeink alapján natív koronária betegek körében az emelkedett Hcy-szint nőknél függetlenül kapcsolódott a CAD jelenlétéhez, míg az emelkedett Lp(a) pedig az MI, vagy a CAD és MI előfordulásához. A Hcy és az Lp(a) együttes emelkedése további kockázat növekedést mutatott CAD-ra a teljes betegcsoportban, a legnagyobbat (több mint 3.5-szoros kockázat növekedést) nőknél. A CAD és MI együtt előfordulása közel háromszoros volt a Hcy- és Lp(a) emelkedett csoportban, míg az MI kockázata majdnem hatszoros az <55 év nőknél. Az SVG betegek körében a Hcy-szint szignifikáns pozitív és független kapcsolatot mutatott az SVG betegség (lumen átmérő csökkenés, %) jelenlét mértékével. Egy 1µmol/L-nyi Hcy szintemelkedés 0,053% lumen átmérő szűkületnövekedéssel/hó állt kapcsolatban, ami teoretikusan +10 µmol/L magasabb Hcy-szint esetén 5 év alatt 32,1% lumen átmérő csökkenést prognosztizál. Az emelkedett Hcy-szintű betegek az átlagnál jelentősebb kockázattal bírnak a vaszkuláris degenerációra. A vizsgálatunkban tapasztaltak alátámasztják szelektált CAD betegek (natív koronária intervención/CABG-n átesettek) körében további kutatások végzését, például a homocisztein-szint csökkentő kezelés hatásának felderítésére. Angol nyelvű összefoglaló: Serious manifestations and complications of coronary artery disease (CAD) are the major cause of natural and premature deaths in developed societies. Due to increasing health care costs, cardiac intervention/prevention is expected to provide more than a mechanical revascularization of affected vascular segments. Despite the widely available sophisticated therapeutic options and medicines degenerative transformations of native coronary arteries/grafts and their complications are serious limitations of life expectancy. Importance of risk factors or comorbidities is often underestimated or their management is ineffective or inadequate. The objective of my research was to examine the role of novel risk factors on native coronary/saphenous venous graft degeneration among CAD patients. Data of nine hundred and fifty-five CAD patients were collected and analyzed from 1999 to 2007 and in a subgroup of 75 CABG-SVG (coronary artery bypass surgery, saphenous venous graft) patients till 2013: data of comorbidities, risk factors, results of repeat selective coronary angiographies were recorded and evaluated. Native coronary artery patients were divided into 4 subgroups based on presence or absence of significant coronary artery stenosis/previous myocardial infarction (MI), patient without significant coronary artery stenosis and MI formed the control group. Seventy-five patients receiving CABG-SVG were divided into subgroups according to their graft status as "intact" (<20%); classified "narrowed" (20-99%) and blocked SVG group at follow-up. Results showed independent relationship in female native coronary patients between elevated Hcy and presence of CAD, while elevated Lp(a) was associated with the presence of MI or MI and CAD together. Combined Hcy and Lp(a) elevation showed higher risk for CAD in the whole patient group, the highest (more than 3.5 fold risk) in women. Presence of CAD and MI was nearly three-fold increased in the Hcy-, and Lp(a) elevated group, whereas risk of MI was almost six-fold increased in women <55 years. Regarding SVG patients Hcy-level has showed significant positive and independent correlation with the presence of SVG disease (lumen diameter reduction,%). 1μmol/L elevation of Hcy was related to 0.053% increase of lumen diameter stenosis per month, which theoretically means that +10 µmol/L higher Hcy level relates to 32.1% decrease in lumen diameter over 5 years. Patients with elevated Hcy have greater risk of vascular degeneration. Experiences of our study may support the need of further researches among selected CAD patients, collecting further results regarding effect on progression of Hcy-lowering treatment.

Read accessible full text

A homocisztein szerepe a natív koronáriák és a véna graftok ateroszklerotikus megbetegedéseiben

Author: Balogh, Emília
Year: 2016
Source: https://dea.lib.unideb.hu/bitstreams/6c799005-4b42-49e4-b0ec-855014338901/download
- 1 -
SHORT THESIS FOR THE DEGREE OF DOCTOR OF
PHYLOSOPHY (PhD)
ROLE OF HOMOCYSTEINE IN
ATHEROSCLEROTIC MANIFESTATIONS OF
NATIVE CORONARY ARTERIES AND VEIN
GRAFTS
Emília Balogh MD
Supe iso : Zsol Kőszegi MD, PhD
UNIVERSITY OF DEBRECENI
Kálmán Laki Doc o al School
Deb ecen, 2016
- 2 -
By Emilia Balogh MD
Supe iso : Zsol Kőszegi MD, PhD
Doc o al School o Kálmán Laki, Uni e si y o Deb ecen
Head o he Examina ion Commi ee: Csongo Kiss, MD, PhD, DSc
Membe s o he Examina ion Commi ee: Noémi Nyolczas, MD, PhD
László Vi ág, MD, PhD, DSc
The Examina ion akes place
a he aining oom o Ins i u e o Pedia ics Dep . o Pedia ic Haema o-
Oncology, In e nal Medicine bldg. „B”., Clinical Cen e,
Uni e si y o Deb ecen on Sep embe 27, 2016, a 11 AM
Head o he De ense Commi ee: Csongo Kiss, MD, PhD, DSc
Re iewe s: And ás Komócsi, MD, PhD, DSc
Józse Szen miklósi, MD, PhD
Membe s o he De ense Commi ee: Noémi Nyolczas, MD, PhD
László Vi ág, MD, PhD, DSc
The PhD De ense akes place
a he Lec u e Hall o Bldg. „A”, Depa men o In e nal Medicine,
Facul y o Medicine, Uni e si y o Deb ecen
on Sep embe 27, 2016, a 1PM
- 3 -
1. INTRODUCTION
My esea ch was ocused on he ole o homocys eine (Hcy) in
a he oscle o ic mani es a ions o na i e co ona y a e ies and enous
g a s.
The co ona y a e y disease (CAD) and i s se e e mani es a ions and
complica ions a e a majo cause o p ema u e mo ali y in de eloped
socie ies.
Degene a i e diseases o na i e co ona y a e ies
Co ona y scle osis is a se o p og essi e eac ions a ising om ch onic
inju ies o he endica dial su ace. The damaged endo helial a ea is
il a ed wi h oxidized lipop o eins and o ms a lipid- ich nec o ic co e
and a ib ous cap. The lesion is slowly calci ying, howe e he ma ginal
a eas emain pe manen ly in il ed by in lamma o y cells.
Degene a i e diseases o ein g a s
Excep om le an e io descending co ona y a e y, saphenous enous
g a s a e used widely o co ona y a e y bypass g a ing (CABG) due
o hei numbe and size a ie y and easy accessibili y o hei easie
p epa a ion. Bu hei long e m pa ency is se iously limi ed. A e en
yea s only 50-60% o he ein g a s emain unc ional. The ein g a
a he omas a e di e en om he na i e essels’ simila lesions: di use,
- 4 -
ci cula , con ains less calci ica ion, ib in ha is hinne o absen , hey
a e p one o up u e and emboli o ma ion. Acco ding o expe imen al
models, ein g a s ha e di e en gene egula ion and gene exp ession
mechanisms and in lamma o y esponses caused by in lamma ion.
Physiology o homocys eine
Homocys eine (Hcy) is a sul u -con aining amino acids, an
in e media e p oduc o he p o ein me abolism. The Hcy connec s h ee
di e en pa hways o he amino acid me abolism: he ola e and he
me hionine cycle, which p o ides C1-pa icules o DNA-, RNA-, and
p o ein-, as well as glu a hione syn hesis. The plasma o al Hcy le el
di e s by age, sex and ace. In heal hy adul s is be ween 7-14 µmol/L.
Hype homocys einemia
Acco ding o ou esen knowledge only > 15µmol/L plasma Hcy has
pa hological ole and i is lis ed in o di e en ca hego ies o mild (15-
30 µmol/L), mode a e (30-100 µmol/L) and se e e (> 100 µmol/L)
hype homocys einemia (hHcy). The homocys eine me abolism is
in luenced by se e al exogenous and endogenous ac o s. Fo he
highes Hcy ele a ion is caused by he inhe i ed de iciency o
cys a hionine-be a-syn hase (CBS) enzyme ha is esponsible o
homocys eine-me ionin ans o ma ion. O he common causes o Hcy
le el ele a ion a e: nu i ion de iciency, lack o i amine B6-, i amin
B12-, and olic acid, inc eased in ake o me hionine, alcoholism,
- 5 -
smoking, co ee consump ion, pe manen ly inac i e li es yle.
Homocys eine le el is also a ec ed by ce ain diseases, eg. diabe es,
cance (b eas -, o a y-, panc eas ca cinoma, acu e lymphoblas ic
leukemia), enal insu iciency, pso iasis, SLE, heuma oid a h i is,
hypo hy oidism, ce ain neu ological diseases (eg. demen ia),
medica ions: MTX, cyclospo ine, ime hop im, con acep i es, olic
acid, B6-, B12- an agonis s, an icon ulsan s, hiazide diu e ics, ni ogen
oxides, ib a es, me o min.
The „excess” o homocys eine o ms disul ide bonds, a ec s
h omboci e agg ega ion and adhesion, inc eases TXA2-, bu educes
p os acyclin le els and induces ascula in lamma ion. Changes
balance o endogenous ib inolysis by inc easing esis ance o ib ine
clo s agains o ib inolysis, inc ease isk o ascula h ombosis. The
hHcy acili a es o ma ion o o oxidized LDL, and choles e ol es e s
and hei depona ion in o endo helial lesions. Th oughou inco po a ing
in o p o eins Hcy gene a es an au oimmune esponse.
Hype homocys einemia and ca dio ascula disease, i amin
p e en ion ials
In he 1960s based on obse a ions o McCully on homocys eine was
cla i ied i s ela ionship wi h a he oscle osis and h omboembolism. In
1975 he has published wi h Wilson he "p o ein heo y" o
a he oscle osis (be ween homocys eine and a he oscle osis) and abou
i s i amin p e en ion. Clinical s udies pe o med since he middle o

- 6 -
1990s ha e e i ied he independen isk ac o ole o hHcy in
ca dio ascula and a he o- h ombo ic diso de s, bu he combined
incidence o ca dio ascula disease ha was achie ed by combined
i amin he apy has se con adic o y esul s.
Mos o he andomized, con olled s udies ha e shown ha educ ion
o plasma Hcy le els by adminis a ion o i amin B6-, o B12- o olic
acid does no imp o e ou comes o ca dio ascula disease. The key o
unde s anding he homocys eine pa adox is cla i ying i s complex
biochemical ole.
2. OBJECTIVES
The ollowing objec i es we e se up:
1-2. Wha a e he ea u es o medium o long- e m mani es a ions o
na i e co ona y a he oscle osis and enous g a degene a ion
associa ed wi h homocys eine?
3-4. Is he e a ela ionship be ween homocys eine and o he isk
ac o s?
5. Is he e a possible a ole o homocys eine in es ima ion ela ed o
co ona y and ein g a disease p og ession in o de o imp o e he
e ec i i y o seconda y p e en ion?
3. METHODS
Design o s udy o na i e co ona ies
- 7 -
A case-con ol s udy: compa ing CAD pa ien s wi h "nega i e" CAD
con ols based on co ona y angiog aphies. We examined isk ac o s
p o ile di e ecy beween pa ien and con ol g oups by collec ing da a
e ospe i ely om clinical da abase.
Ou aim was o in es iga e he CAD speci ic isk ac o s be ween
pa ien g oups by collec ing da a om clinical da abase. The con ol
g oup was o med by pa ien s who we e admi ed wi h suspec ed CAD,
bu co ona y lesions we e no con i med.
Design o s udy o enous g a s
Co ela ion e alua ion be ween isk ac o s and g a s a us among
pa ien s who unde wen CABG su ge y, and ecei ed a leas one
saphenous ein g a . The co ona y es s has been pe o med a leas
one yea a e hea su ge y, and was based on clinical indica ions.
The esea ch was ca ied ou be ween 2001-2013, in a single cen e , a
he Uni e si y o Deb ecen Dep . O Ca diology in ha mony wi h he
Decla a ion o Helsinki and au ho i y egula ions. The esea ch has
been no i ied o he Ins i u ional E hics Commission. The in ol ed
pa ien s ecei ed p io o al and w i en in o ma ion abou he possibili y
o p ocessing da a o esea ch. They all ga e hei w i en consen ,
which was a chi ed oge he wi h hei clinical documen a ion.
Da a was collec ed om elec onic da abase (MedSolu ion) o he
Ins i u e o Ca diology Clinical Cen e Uni e si y o Deb ecen. Da a o
- 8 -
pe sonal iden i ica ion (name, da e o bi h, social secu i y numbe ),
was masked h oughou he s a is ical analysis. The physical
examina ion and collec ion o da a o all pa ien s was pe o med by
me.
Selec ion o pa ien s wi h na i e co ona ies
A 1010 pa ien s we e included among hose admi ed o DE KK
Ins i u e o Ca diology du ing 2001-2002 wi h suspec ed CAD,
pe o med a selec i e co ona y angiog am.
Selec ion o pa ien s wi h ein g a s
The s udy included 237 ( wo hund ed hi y-se en) pa ien s who we e
admi ed o DE KK Ins i u e o Ca diology du ing 2001-2002, ollowed
by CABG wi h a leas one saphenous ein g a .
Reco ded da a
Fo he pa ien s included he ollowing da a we e eco ded: amily
his o y o a he oscle osis/complica ions, p e ious myoca dial
in a c ion, hype lipidemia, smoking his o y and habi s, high blood
p essu e, diabe es, ca o id s enosis, pe iphe al a e ial ascula disease,
women's ho monal s a us. The ollowing demog aphic in o ma ion was
eco ded: age (yea s), sex, body weigh (kg), heigh (me e s), body
mass index, i al signs, and le en icula ejec ion ac ion, ca diac
unc ion.
- 9 -
Co ona y and ein g a s a us cla i ica ion
Selec i e angiog aphy examina ions and hei assessmen we e ca ied
by expe ienced ca diologis s. The s anda d es me hodology was done
h oughou igh emo al a e y app oach by Judkins echnic. The
s anda d iews consis ed o a leas 3 sho s o he le co ona y
a e y/g a b anches and o wo s anda d iew shoo ing 12.5 ames/
sec speed om he igh co ona y b anches by Philips In eg is ype o
x- ay machine (In u is Viewe Li e Sui e 1.0, Philips, The
Ne he lands). Assessmen o co ona y a e y lumen diame e na owing
consis ed o de e mina ing localisa ion and deg ee o s enoses (%). The
numbe o g a s, hei localiza ion and g a in e en ions ha e been
documen ed.
Co ona y angiog aphies pe o med wi hin a yea a e CABG ha e
been excluded om e alua ion – o sepa a e cases due o echnical e o
o p ema u e g a h ombosis.
The diagnosis o SVG disease was based on independen judgemen o
epea co ona y angiog aphies by 2 expe ca diologis s; SVGs we e
classi ied acco ding o hei “lumen s a us” (diame e s enosis; [%]) a
epea co ona y angiog aphy as “in ac ” wi h a <20% lumen diame e
educ ion, “na owed” wi h a lumen diame e s enosis be ween 20-
99%, and “occluded” (closed lumen). Pa ien s ha ing >1 SVG wi h
di e en g a s a us a ollow up we e anked acco ding o he mo e
- 16 -
8. PUBLICATIONS

- 17 -
- 18 -
- 19 -
- 20 -
THANKS GIVING
I would like o exp ess my hanks o all hose who helped me pe o m
his scien i ic esea ch, as well as in he p epa a ion o his PhD hesis:
p o esso D . Is án Édes, p o esso D . Is án Czu iga, p o esso D .
László Muszbek, D . Zsuzsanna Be eczky, D . É a Ka ona, D . László
Balkay, E zsébe Ráczné Csiha, Gábo Ká olyi, Balázs Nyul.
I would like o hank o all my p e ious colleauges a he Ca diology
Ins i u e, o me Hea and Lung Clinic, Hea Su ge y Depa men ,
Hemodynamic Labo a o y, Clinical Labo a o y Ins i u e, Clinical
Labo a o y Resea ch Depa men .
I would like o hank he suppo o my u o , D . Zsol Kőszegi and
inally, wi h deep g a i ude and lo e I hink o my pa en s and my
amily: Wi hou hei suppo I could no each my goals.